Diffuse plane normolipemic xanthomatosis and necrobiotic xanthogranuloma associated with monoclonal gammopathy - Determining the disease stage with PET-CT and treatment experience. Two case studies and literature review;Difuzní plošná normolipemická xantomatóza a nekrobiotický xantogranulom, asociované s monoklonální gamapatií - Přínos PET-CT pro stanovení rozsahu nemoci a zkušenosti s léčbou. Popis dvou případů a přehled literatury

Vnitrni Lekarstvi

Volumn 56, Issue 11, 2010, Pages 1158-1168

  Adam, Zdeněk ^a   Zahradova L ^a   Krejci M ^a   Pour, L ^a   Koukalova R ^b   Rehak Z ^b   Feit, J ^a   Kren L ^a   Mechl, M ^a   Vaskus V ^c   Sirotkova A ^c   Hajek R ^a   Mayer, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b Oddeleni Nuklearni Mediciny Masarykova Onkologickeho Ustavu   (Czech Republic)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Bortezomib; Cyclophosphamide; Dexamethasone; Monoclonal gammopathy; Multiple myeloma; Necrobiotic xanthogranuloma; Normolipemic xanthomas; PET CT imaging

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; GLUCOSE; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; PARAPROTEIN;

CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPHADENOPATHY; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; POSITRON EMISSION TOMOGRAPHY; RETROPERITONEUM; REVIEW; SKIN DISEASE; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS TISSUE; XANTHOGRANULOMA; XANTHOMATOSIS; IMMUNOLOGY; MALE; MIDDLE AGED; NECROBIOTIC XANTHOGRANULOMA; PATHOLOGY;

HUMANS; MALE; MIDDLE AGED; MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE; NECROBIOTIC XANTHOGRANULOMA; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; XANTHOMATOSIS;

EID: 78650025182     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Janssen D, Fölster-Holst R, Harms D et al. Clonality in juvenile xanthogranuloma. Am J Surg Pathol 2007; 31: 812-813.
2. Decaux O, Laurat E, Perlat A et al. Systemic manifestations of monoclonal gammopathy. Eur J Intern Med 2009; 20: 457-461.
3. Alexander AS, Turner R, Uniate L et al. Xanthoma disseminatum: a case report and literature review. Br J Radiol 2005; 78: 153-157.
4. Vick VL, Wilson MW, Fleming JC et al. Orbital and eyelid manifestations of xanthogranulomatous diseases. Orbit 2006; 25: 221-225.
5. Asarch A, Thiele JJ, Ashby-Richardson et al. Cutaneous disseminated xanthogranuloma in adult: a case report and review of the literature. Cutis 2009; 83: 243-249.
6. Altman J, Winkelmann RK. Diffuse normolipemic planae xanthoma. Generalized xanthelasma. Arch Dermatol 1962; 85: 633-640.
7. Lynch PJ, Winkelmann RK. Generalized plane xanthoma and systemic disease. Arch Dermatol 1966; 93: 639-640.
8. Williford PM, White WL, Jorizzo JL et al. The spectrum of normolipemic plane xanthoma. Am J Dermatopathol 1993; 15: 572-575.
9. Taylor JS, Lewis LA Battle JD Jr et al. Plane xanthoma and multiple myeloma with lipoprotein-paraprotein complexing. Arch Dermatol 1978; 114: 425-431.
10. Marcoval J, Moreno A, Bordas X et al. Diffuse plane xanthoma: clinicopathologic study of 8 cases. J Am Acad Dermatol 1998; 39: 439-442.
11. Wood AJ, Wagner MV, Abbott JJ et al. Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol 2009; 145: 279-284.
12. Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1980; 3: 257-270.
13. Ugurlu S, Bartley GB, Gibbon LE. Necrobiotic xanthogranuloma: long term outcome of ocular and systemic involvement. Am J Ophthalmol 2000; 129: 651-657.
14. Mehregan DA, Winkelmann RK. Necrobiotic xanthogranuloma. Arch Dermatol 1992; 128: 94-100.
15. Finan MC, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. A review of 22 cases. Medicine (Baltimore) 1986; 65: 376-388.
16. Martínez Fernández M, Rodríguez Prieto MA, González J et al. Necrobiotic xanthogranloma associated with myeloma. J Eur Acad Dermatol Venereol 2004; 18: 328-331.
17. Oumeish OY, Oumeish I, Tarawneh M et al. Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: the first case reported in the literature and review of the literature. Int J Dermatol 2006; 45: 306-310.
18. Winkelmann RK, Dahl PR, Perniciaro C. Asteroid bodies and other cytoplasmic inclusions in necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1998; 38: 967-970.
19. Randell PL, Heenan PJ. Necrobiotic xanthogranuloma with paraproteinaemia. Australas J Dermatol 1999; 40: 114-115.
20. Robertson DM, Winkelmann RK. Ophthalmic features of necrobiotic xanthogranuloma with paraproteinemia. Am J Ophthalmol 1984; 97: 173-183.
21. Adam Z, Balšíková K, Pour L et al. Diabetes insipidus, následovaný po 4 letech dysartrií a lehkou pravostrannou hemiparézou - první klinické příznaky Erdheimovy-Chesterovy nemoci. Popis a zobrazení případu s přehledem informací o této nemoci. Vnitřní Lék 2009; 55: 1173-118.
22. Martínez Fernández M, Rodríguez Prieto MA, González J et al. Necrobiotic xanthogranloma associated with myeloma. J Eur Acad Dermatol Venereol 2004; 18: 328-331.
23. Fernández-Herrera J, Pedraz J. Necrobiotic xanthogranuloma. Semin Cutan Med Surg 2007; 26: 108-113.
24. Machado S, Alves R, Lima M et al. Cutaneous necrobiotic xanthogranuloma (NXG): successfully treated with low dose chlorambucil. Eur J Dermatol 2001; 11: 458-462. (Pubitemid 32801346)
25. Hunter L, Burry AF. Necrobiotic xanthogranuloma: a systemic disease with paraproteinemia. Patology 1985; 17: 533-536. (Pubitemid 15242589)
26. Fortson JS, Schroeter AL. Necrobiotic xanthogranuloma with IgA paraproteinemia and extracutaneous involvement. Am J Dermatopathol 1990; 12: 579-584.
27. Bara C, Barbarot S, Hamitou M et al. Systemic necrobiotic xanthogranuloma with initial pericardial and pulmonary involvement. Ann Dermatol Venereol 2003; 130: 341-344. (Pubitemid 36542236)
28. Novak PM, Robbins TO, Winkelmann RK. Necrobiotic xanthogranuloma with myocardial lesions and nodular transformation of the liver. Hum Pathol 1992; 23: 195-196.
29. Shah KC, Poonnoose SI, Georgie R et al. Necrobiotix xanthogranuloma with cutaneous and cerebral manifestations. Case report and review of the literature. J Neurosurg 2004; 100: 1111-1114. (Pubitemid 38661631)
30. Umbert I, Winkelmann RK. Necrobiotic xanthogranuloma with cardiac involvement. Br J Dermatol 1995; 133: 438-443.
31. Yasukawa K, Kato N, Hamasaka A et al. Necrobiotic xanthogranuloma: isolated skeletal and muscle involvement and unusual changes. J Am Acad Dermatol 2005; 52: 729-731. (Pubitemid 40585468)
32. Winkelmann RK, Litzow MR, Umbert IJ et al. Giant cell granulomatous pulmonary and myocardial lesions in necrobiotic xanthogranuloma with paraproteinemia. Mayo Clin Proc 1997; 72: 1028-1033.
33. Bakir B, Unuvar E, Terzibasioglu E et al. Atypical lung involvement in a patient with systemic juvenile xanthogranuloma. Pediatr Radiol 2007; 37: 325-327.
34. Amer R, Peer J. Pappo O et al. Necrobiotic xanthogranuloma associated with choroidal infiltration and syncytial giant cell hepatitis. J Neuroophthalmol 2005; 25: 189-192. (Pubitemid 41306675)
35. Betts CM, Pasquinelli C, Costa AM et al. Necrobiotic xanthogranuloma without periorbital involvement: an ultrastructural investigation. Ultrastruct Pathol 2001; 25: 437-444.
36. Orsey A, Paessler M, Lange BJ et al. Central nervous system juvenile xanthogranuloma with malignant transformation. Pediatr Blood Cancer 2008; 50: 927-930.
37. Ozcelik U, Dogru D, Akcoren Z et al. Xanthoma disseminatum: a child with respiratory system involvement and bronchiectasias. Pediatr Pulmonol 2005; 39: 84-87.
38. Smith HC, Sargent LD, Lundin DB. Necrobiotic xanthogranuloma of the chest wall. Dermatol Online J 2006; 12: 12-16.
39. Stockman A, Delanghe J, Geerts ML et al. Diffuse plane normolipaemic xanthomatosis in a patient with chronic lymphatic leukaemia and monoclonal gammopathy. Dermatology 2002; 204: 351-354.
40. Stork J, Kodetová D, Vosmík E et al. Necrobiotic xanthogranuloma presenting as a solitary tumor. Am J Dermatopathol 2000; 22: 453-456.
41. Spicknall KE, Mehregan DA et al. Necrobiotic xanthogranuloma. Int J Dermatol 2009; 48: 1-10.
42. Tucker NA, Discepola MJ, Blanco G et al. Necrobiotic xanthogranuloma without dermatologic involvement. Can J Ophthalmol 1997; 32: 396-399.
43. Ferrara G, Palombi N, Lipizzi A et al. Nonnecrobiotic necrobiotic xanthogranuloma. Am J Dermatopathol 2007; 29: 306-308.
44. Bullock JD, Bartley GB, Campbell RJ et al. Necrobiotic xanthogranuloma with paraproteinemia. Case report and pathogenetic theory. Trans Am Ophthalmol Soc 1986; 84: 342-354.
45. Hafner O, Witte T, Schmidt RE et al. Necrobiotic xanthogranuloma in IgG κ plasmacytoma and Quincke edema. Hautarzt 1994; 45: 339-343.
46. Matsuura F, Yamashita S, Hirano K et al. Activation of monocytes in vivo causes intracellular accumulation of lipoprotein-derived lipids and marked hypocholesterolemia - a possible pathogenesis of necrobiotic xanthogranuloma. Atheroslerosis 1999; 142: 355-365.
47. Jeziorska M, Hassan A, Mackness MI et al. Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis. J Clin Pathol 2003; 56: 64-68.
48. Langlois S, Brochot P, Reguiai Z et al. Necrobiotic xanthogranuloma with multiple myeloma. Case report and pathogenic hypotheses. Joint Bone Spine 2006; 73: 120-122.
49. Zeiger B, Eisendle K, Mensing C et al. Detection of spirochetal micro-organism by focus bloating microscopy in necrobiotic xanthogranuloma. J Am Acad Dermatol 2007; 57: 1026-1030.
50. Chang SE, Lee WS, Lee MW et al. A case of necrobiotic xanthogranuloma without paraproteinemia presenting as a solitary tumor on the thigh. Int J Dermatol 2003; 42: 470-472.
51. Yagci B, Varan A, Altinock G et al. Xanthoma disseminatum in a child with cranial involvement. J Pediatr Hematol Oncol 2008; 30: 310-312.
52. Weitzman S, Jaffe R. Uncommon histiocytic disorders: the non Langerhans cell histiocytoses. Pediatr Blood Cancer 2005; 45: 256-264.
53. Moore FO, Berne JD, Fox AD. Mesenteric panniculitis and Erdheim-Chester disease: xanthogranulomatous diseases confused with malignancy. J Am Coll Surg 2007; 204: 326-327.
54. Nestle FO, Hofbauer G, Burg G. Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgGλ type. Dermatology 1999; 198: 434-435.
55. Wee SA, Shupack JL. Necrobiotic xanthogranuloma. Dermatol Online J 2005; 11: 24-25.
56. Cornblath WT, Dotan SA, Trobe JD et al. Varied clinical spectrum of necrobiotic xanthogranuloma. Ophthalmology 1992; 99: 103-107.
57. Einer VM, Mintz R, Demirci H et al. Local corticosteroid treatment of eyelid and orbital xanthogranuloma. Trans Am Ophthalmol Soc 2005; 103: 69-73.
58. Sabet LM, Wexler D, Salama S et al. An unusual cause of refractive chronic bilateral leg ulceration. J Cutan Med Surg 2004; 8: 432-437.
59. Chave TA, Chowdhury MM, Holt PJ. Recalcintrant necrobiotic xantohogranuloma responding do pulsed high-dose dexamethasone plus maintenance therapy with oral prednisone. Br J Dermatol 2001; 144: 158-161.
60. Valentine EA, Friedman HD, Zamkoff KW et al. Necrobiotic xanthogranuloma with IgA multiple myeloma: a case report and literature review. Am J Hematol 1990; 35: 283-285.
61. Venencie PY, Le Bras P, Toan ND et al. Recombinant interferon α-2b treatment of necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1995; 32: 666-667.
62. Scupham RK, Fretzin DB. Necrobiotic xanthogranuloma with paraproteinemia. Arch Pathol Lab Med 1989; 113: 1389-1391.
63. Plotnick H, Taniguchi Y, Hashimoto K et al. Periorbital necrobiotix xanthogranuloma and stage I multiple myeloma. Ultrastructure and response to pulsed dexamethasone documented by magnetic resonance imaging. J Am Acad Dermatol 1991; 25: 373-377.
64. Kossard S, Chow E, Wilkinson B et al. Lipid and giant cell poor necrobiotic xanthogranuloma. J Cutan Pathol 2000; 27: 374-378. (Pubitemid 30427115)
65. Wells J, Gillespie R, Zardawi I. A case of recalcitrant necrobiotic xanthogranuloma. Australas J Dermarol 2004; 45: 213-215.
66. Meyer S, Szeimies RM, Landthaler M et al. Cyclophosphamide-dexamethasone pulsed therapy for treatment of recalcitrant necrobiotic xanthogranuloma with paraproteinemia and ocular involvement. Br J Dermatol 2005; 153: 443-445. (Pubitemid 41228451)
67. Stover DG, Alapati S, Regueira O et al. Treatment of juvenile xanthogranuloma. Pediatr Blood Cancer 2008; 51: 130-133.
68. Seaton, ED, Pillai GJ, Chu AC. Treatment of xanthoma disseminatum with cylophosphamide. Br J Dermatol 2004; 150: 346-349.
69. Flann S, Wain EM, Halpern S et al. Necrobiotic xanthogranuloma with paraproteinaemia. Clin Exp Dermatol 2006; 31: 248-251.
70. Chave TA, Hutchinson PE. Necrobiotic xanthogranuloma with two monoclonal paraproteins and no periorbital involvement at presentation. Clin Exp Dermatol 2001; 26: 493-496.
71. Hauser C, Schifferli J, Saurat JH. Complement consumption in a patient with necrobiotic xanthogranuloma and paraproteinemia. J Am Acad Dermatol 1991; 24: 908-911.
72. Torabian SM, Fazel N, Knuttel R. Necrobiotic xanthogranuloma treated with chlorambucil. Dermatol Online J 2006; 12: 11-12.
73. Luck J, Layton A, Noble BA. Necrobiotix xanthogranuloma with orbital involvement. J R Soc Med 1992; 85: 357-358.
74. Criado PR, Vasconcellos C, Pegas JR et al. Necrobiotic xanthogranuloma with λ paraproteinemia: case report of successful treatment with melphalan and prednisone. J Dermatolog Treat 2002; 13: 87-89. (Pubitemid 34670367)
75. Ito Y, Nishimura K, Yamanaka K et al. Necrobiotic xanthogranuloma with paraproteinemia: an atypical case. J Dtsch Dermatol Ges 2008; 6: 40-43.
76. Russo CG. Necrobiotic xanthogranuloma with scleroderma. Cutis 2002; 70: 311-316.
77. Saeki H, Tomita M, Kai H et al. Necrobiotic xanthogranuloma with paraproteinemia successfully treated with melphalan, prednisolone and skin graft. J Dermatol 2007; 34: 795-797.
78. Wilhelmus KR, Yen MT, Rice L et al. Necrobiotic xanthogranuloma with posterior scleritis. Arch Ophthalmol 2006; 124: 748.
79. Ziemer M, Wedding U, Sander CS et al. Necrobiotic xanthogranuloma - rapid progression under treatment with melphalan. Eur J Dermatol 2005; 15: 363-365.
80. Hayden A, Wilson DJ, Rosenbaum JT. Management of orbital xanthogranuloma with methotrexate. Br J Ophthalmol 2007; 91: 434-436.
81. Georgiou S, Monastirli A, Kapranos N et al. Interferon α monotherapy for necrobiotic xanthogranuloma. Acta Derm Venereol 1999; 79: 484-485.
82. Finelli LG, Ratz JL. Plasmapheresis, a treatment modality for necrobiotic xanthogranuloma. J Am Acad Dermatol 1987; 17: 351-354.
83. Lorenz S, Hohenleutner S, Hohenleutner U et al. Treatment of diffuse plane xanthoma of the face with the erbium: YAG laser. Arch Dermatol 2001; 137: 1413-1415.
84. Vieira V, Del Pozo J, Martínez W et al. Necrobiotic xanthogranuloma associated with lymphoplasmacytic lymphoma. Palliative treatment with carbon dioxide laser. Eur J Dermatol 2005; 15: 182-185.
85. Goede JS, Misselwitz B, Taverna C et al. Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation. Ann Hematol 2007; 86: 303-306.
86. Silapunt S, Chon SY. Generalized necrobiotic xanthogranuloma successfully treated with lenalidomide. J Drugs Dermatol 2010; 9: 273-276.
87. Histiocyte society. Available from: www.histiocytesociety.org/site/.